318 related articles for article (PubMed ID: 27260836)
1. Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.
Ando K; Tomimura K; Sazdovitch V; Suain V; Yilmaz Z; Authelet M; Ndjim M; Vergara C; Belkouch M; Potier MC; Duyckaerts C; Brion JP
Neurobiol Dis; 2016 Oct; 94():32-43. PubMed ID: 27260836
[TBL] [Abstract][Full Text] [Related]
2. Picalm reduction exacerbates tau pathology in a murine tauopathy model.
Ando K; De Decker R; Vergara C; Yilmaz Z; Mansour S; Suain V; Sleegers K; de Fisenne MA; Houben S; Potier MC; Duyckaerts C; Watanabe T; Buée L; Leroy K; Brion JP
Acta Neuropathol; 2020 Apr; 139(4):773-789. PubMed ID: 31925534
[TBL] [Abstract][Full Text] [Related]
3. [Neuropathology of tauopathy].
Yoshida M
Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
[TBL] [Abstract][Full Text] [Related]
4. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
[TBL] [Abstract][Full Text] [Related]
5. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).
Dickson DW; Kouri N; Murray ME; Josephs KA
J Mol Neurosci; 2011 Nov; 45(3):384-9. PubMed ID: 21720721
[TBL] [Abstract][Full Text] [Related]
6. DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders.
Kumaran R; Kingsbury A; Coulter I; Lashley T; Williams D; de Silva R; Mann D; Revesz T; Lees A; Bandopadhyay R
Neurobiol Dis; 2007 Oct; 28(1):122-32. PubMed ID: 17719794
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
Briel N; Pratsch K; Roeber S; Arzberger T; Herms J
Brain Pathol; 2021 Jul; 31(4):e12914. PubMed ID: 33089580
[TBL] [Abstract][Full Text] [Related]
9. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
Vingtdeux V; Davies P; Dickson DW; Marambaud P
Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
[TBL] [Abstract][Full Text] [Related]
10. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.
Yoshida M
Neuropathology; 2006 Oct; 26(5):457-70. PubMed ID: 17080726
[TBL] [Abstract][Full Text] [Related]
11. Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
Martínez-Maldonado A; Ontiveros-Torres MÁ; Harrington CR; Montiel-Sosa JF; Prandiz RG; Bocanegra-López P; Sorsby-Vargas AM; Bravo-Muñoz M; Florán-Garduño B; Villanueva-Fierro I; Perry G; Garcés-Ramírez L; de la Cruz F; Martínez-Robles S; Pacheco-Herrero M; Luna-Muñoz J
J Alzheimers Dis; 2021; 79(4):1517-1531. PubMed ID: 33459640
[TBL] [Abstract][Full Text] [Related]
12. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
13. Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains.
Ando K; Brion JP; Stygelbout V; Suain V; Authelet M; Dedecker R; Chanut A; Lacor P; Lavaur J; Sazdovitch V; Rogaeva E; Potier MC; Duyckaerts C
Acta Neuropathol; 2013 Jun; 125(6):861-78. PubMed ID: 23589030
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Blanco R; Carmona M; Ribera R; Goutan E; Puig B; Rey MJ; Cardozo A; Viñals F; Ribalta T
Brain Pathol; 2001 Apr; 11(2):144-58. PubMed ID: 11303790
[TBL] [Abstract][Full Text] [Related]
15. Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer's disease, progressive supranuclear palsy and dementia with Lewy bodies.
Puangmalai N; Bhatt N; Montalbano M; Sengupta U; Gaikwad S; Ventura F; McAllen S; Ellsworth A; Garcia S; Kayed R
Cell Death Dis; 2020 May; 11(5):314. PubMed ID: 32366836
[TBL] [Abstract][Full Text] [Related]
16. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
[TBL] [Abstract][Full Text] [Related]
17. Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies.
Pires G; McElligott S; Drusinsky S; Halliday G; Potier MC; Wisniewski T; Drummond E
Acta Neuropathol Commun; 2019 Dec; 7(1):195. PubMed ID: 31796108
[TBL] [Abstract][Full Text] [Related]
18. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H
Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439
[TBL] [Abstract][Full Text] [Related]
19. Selective tau tyrosine nitration in non-AD tauopathies.
Reyes JF; Geula C; Vana L; Binder LI
Acta Neuropathol; 2012 Jan; 123(1):119-32. PubMed ID: 22057784
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
